查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1837192

快速動物試驗市場按產品類型、動物類型、技術、應用、最終用戶和分銷管道分類－2025-2032年全球預測

Veterinary Rapid Test Market by Product Type, Animal Type, Technology, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，快速動物試驗市場規模將達到 14.4285 億美元，複合年成長率為 9.89%。

關鍵市場統計數據
基準年 2024 6.7839億美元
預計年份：2025年 7.4501億美元
預測年份 2032 14.4285億美元
複合年成長率 (%) 9.89%

一份簡潔的策略方向報告，概述了快速動物試驗生態系統以及影響診斷創新和市場接受度的匯聚因素。

本執行摘要總結了快速動物偵測的現況和策略訊號，為領導者提供簡潔明了、切實可行的決策依據。快速動物診斷技術已成為及時進行臨床干預、畜群健康管理以及透過早期檢測保護動物和人類群體的監測計劃的關鍵推動因素。檢測化學、即時檢測平台和分散式檢查模式的進步顯著提高了人們對診斷速度、易用性和與臨床工作流程整合的期望。

此外，法律規範和終端用戶偏好也在同步演變，迫使製造商和服務供應商調整產品設計，以滿足分析效能、易用性和與數位醫療記錄的互通性等要求。因此，相關人員必須兼顧技術創新與實際考量，例如供應鏈韌性、獸醫人員培訓要求以及在不同實踐環境中的成本效益。以下章節將探討變革性轉變、關稅相關動態、市場區隔洞察、區域考量、公司層面策略、可操作說明、方法論以及簡明結論，以引導管理者做出明智的策略選擇。

技術成熟度、分散式醫療服務、監管完善性和供應鏈韌性如何共同重塑獸醫快速診斷的採用模式

由於技術的成熟、醫療服務模式的轉變以及人們對即時診斷期望的不斷提高，獸醫快速檢測領域正在經歷顯著變化。即時檢測平台正從單一分析物讀數發展到多重分析，從而在農場、診所和社區層面提供更廣泛的臨床價值。檢測靈敏度和特異性的同步提升正在縮小快速檢測與實驗室診斷之間的表現差距，使臨床醫生能夠在首次就診時做出更有把握的治療決策。

醫療服務路徑的轉變也將影響需求模式。遠端醫療和遠距會診服務越來越依賴分散式檢查來輔助虛擬臨床決策，而綜合牛管理平台則需要能夠將資料傳輸到分析系統進行疾病監測和生物安全規劃的診斷方法。監管機構正不斷完善其獸醫診斷指南，強調可追溯性、驗證標準和上市後監管。

供應鏈的考量代表著另一個變革方向。那些實現採購多元化、在地化生產並設計出對低溫運輸要求更為簡化的產品的製造商，將更能抵禦各種干擾。此外，相關人員也越來越重視以使用者為中心的設計。針對訓練需求極低、結果解讀迅速的檢測方法，正受到獸醫技術人員和生產者的青睞，他們既追求速度，也注重結果的清晰度。總而言之，這些轉變共同創造了一個環境：技術上的精湛與操作上的實用性必須並存，才能實現更廣泛的應用和持續的臨床影響。

2025年關稅變化和貿易政策轉變將如何重塑診斷服務提供者的供應鏈佈局、採購行為和區域商業化策略？

2025年關稅調整和貿易政策調整的累積影響，為診斷試劑製造商和經銷商的採購、生產佈局決策和定價策略帶來了新的商業性考量。關稅壓力促使企業重新評估其跨境供應鏈，考察近岸外包機會，並重新思考如何將高價值零件分配到區域製造地，以減輕關稅的影響。這些調整不僅限於交易層面，還會影響企業在最終組裝、品管實驗室和庫存中心選址方面的策略選擇，以確保及時向臨床實驗室、獸醫診所和現場作業機構交付產品。

同時，關稅主導的成本動態正在改變供應商與大型機構買家之間的合約談判。採購團隊越來越要求合約條款中包含關稅波動因素，並傾向於選擇能夠證明其到岸成本穩定的供應商。隨著企業調整供應商組合，擁有靈活生產模式的小型創新企業或許能夠憑藉應對力或特定領域的性能優勢展開競爭，而大型傳統企業則可能需要利用其規模和供應鏈控制來保護利潤並維持價格競爭力。

此外，關稅使得分銷通路策略變得更加重要。能夠成功將直銷與本地化最佳化的經銷商夥伴關係相結合的公司，可以降低海關延誤的風險，並促進跨司法管轄區的收入確認。在此背景下，對海關專業知識、本地監管協調和供應鏈透明度的戰略投資不再是後勤部門考慮因素，而是商業規劃的關鍵組成部分。

深入了解產品類型、動物類別、分析技術、臨床應用、使用者類型和通路如何相互作用，從而影響開發重點和商業化策略。

關鍵的細分洞察揭示了不同檢測形式、動物群體、分析技術、臨床應用、終端用戶和通路的差異化需求如何影響產品開發和上市決策。根據產品類型，診斷試劑可分為酵素結合免疫吸附檢測法(ELISA) 和側向層析免疫檢測分析。 ELISA 可進一步分為競爭性、直接、間接和夾心法，而側向層析免疫分析則發展為競爭性、多重和夾心法設計，以平衡通量、靈敏度和簡便性。依動物類型，診斷試劑可分為伴侶動物和家畜兩類。輔助型應用程式主要針對貓和狗，著重於門診臨床的便利性。家畜診斷主要針對牛、雞和豬，群體篩檢、速度和成本效益是關鍵標準。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將照護現場快速診斷檢測納入常規牲畜健康管理，以降低疾病爆發的風險
  • 採用多重橫向流動化驗同時檢測現場多種動物病原體
  • 開發用於農場通用感染疾病即時檢測的攜帶式微流體裝置
  • 小型動物診所和動物收容所對基於智慧型手機的快速免疫檢測平台的需求日益成長
  • 生物技術公司與獸醫協會合作，旨在規範整個全部區域的快速檢測檢驗通訊協定。
  • 新興的基於 CRISPR 的診斷檢測方法提高了在臨床環境中早期發現動物健康威脅的敏感度。
  • 對專注於恒溫核酸增幅以進行牲畜疾病現場檢測的獸醫診斷Start-Ups的投資增加

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按產品類型分類的快速動物實驗市場

  • 酵素結合免疫吸附試驗
    • 競爭法
    • 直接法
    • 間接法
    • 三明治法
  • 側向流動免疫檢測
    • 競爭法
    • 連接複用方法
    • 三明治法

第9章 按動物類型分類的快速動物實驗市場

  • 伴侶動物
    • 貓
    • 狗
  • 家畜
    • 牛
    • 家禽
    • 豬

第10章 按技術分類的快速動物實驗市場

  • 比色分析技術
  • 免疫檢測
    • 化學冷光
    • ELISA
    • 螢光
    • 側向流
  • 分子診斷
    • 等溫擴增
      • 燈
      • RPA
    • PCR
      • 數位PCR
      • 定量PCR

第11章 快速動物檢測市場（依應用領域分類）

  • 基因檢測
    • 突變檢測
    • 物種鑑定
  • 荷爾蒙檢測
    • 生殖
    • 甲狀腺
  • 感染疾病
    • 細菌
    • 真菌
    • 病毒性的
  • 寄生蟲感染疾病
    • 體外寄生蟲
    • 體內寄生蟲

第12章：按最終用戶分類的快速動物測試市場

  • 臨床實驗室
  • 藥局
  • 研究所
  • 獸醫診所

第13章 快速動物實驗市場（依通路分類）

  • 直銷
  • 電子商務
  • 零售

第14章：按地區分類的快速動物檢測市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 快速動物實驗市場（依群體分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國快速動物試驗市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • IDEXX Laboratories, Inc.
    • Zoetis Inc.
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc.
    • Heska Corporation
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Bimeda, Inc.
    • ACON Laboratories, Inc.
    • BioNote Co., Ltd.
Product Code: MRR-034B5003039C

The Veterinary Rapid Test Market is projected to grow by USD 1,442.85 million at a CAGR of 9.89% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 678.39 million
Estimated Year [2025] USD 745.01 million
Forecast Year [2032] USD 1,442.85 million
CAGR (%) 9.89%

A concise strategic orientation that frames the veterinary rapid test ecosystem and the converging forces shaping diagnostics innovation and market adoption

This executive summary synthesizes contemporary developments and strategic signals in the veterinary rapid test landscape to equip leaders with a concise, actionable foundation for decision-making. Rapid diagnostic technologies for animals have emerged as critical enablers of timely clinical intervention, herd health management, and surveillance programs that protect both animal and human populations through early detection. Advances in assay chemistry, point-of-care platforms, and decentralized testing models have collectively shifted expectations for diagnostic speed, usability, and integration with clinical workflows.

Moreover, regulatory frameworks and end-user preferences are evolving in parallel, prompting manufacturers and service providers to align product design with requirements for analytical performance, ease of use, and interoperability with digital health records. As a result, stakeholders must reconcile technical innovation with practical considerations such as supply chain resilience, training requirements for veterinary staff, and cost-effectiveness in diverse practice settings. The following sections unpack transformative shifts, tariff-related dynamics, segmentation insights, regional considerations, company-level strategies, actionable recommendations, methodology, and a concise conclusion to guide executives toward informed strategic choices.

How technological maturation, decentralized care delivery, regulatory refinement, and supply chain resilience are jointly reshaping veterinary rapid diagnostic adoption patterns

The veterinary rapid test landscape is undergoing transformative shifts driven by technological maturation, shifting care delivery models, and heightened expectations for diagnostic immediacy. Point-of-care platforms have progressed from single-analyte readouts to multiplex-capable formats that deliver broader clinical value at the farm, clinic, and community level. Concurrent improvements in assay sensitivity and specificity have narrowed the performance gap between rapid tests and laboratory-based diagnostics, enabling clinicians to make higher-confidence treatment decisions at the first encounter.

Transitioning care pathways also influence demand patterns. Telemedicine and remote consultation services increasingly rely on decentralized testing to inform virtual clinical decision-making, while integrated herd-management platforms demand diagnostics that stream data into analytics systems for disease monitoring and biosecurity planning. Regulatory authorities are continuing to refine guidance for veterinary diagnostics, emphasizing traceability, validation standards, and post-market surveillance, which elevates the bar for manufacturers seeking reproducible clinical performance.

Supply chain considerations represent an additional axis of change. Manufacturers that diversify sourcing, localize production, or design products with simplified cold-chain requirements strengthen their resilience to disruptions. Finally, stakeholders increasingly prioritize user-centered design; tests optimized for minimal training and rapid interpretation gain traction among veterinary technicians and producers who require both speed and clarity. Taken together, these shifts create an environment in which technological sophistication and operational practicality must co-evolve to enable broader adoption and sustained clinical impact.

How 2025 tariff dynamics and trade policy shifts are reshaping supply chain footprints procurement behavior and regional commercialization strategies for diagnostic providers

The cumulative impact of tariff changes and trade policy adjustments in 2025 has introduced new commercial considerations across procurement, manufacturing footprint decisions, and pricing strategies for diagnostic manufacturers and distributors. Tariff pressures have incentivized companies to reassess cross-border supply chains, evaluate nearshoring opportunities, and reconsider the allocation of high-value components to regional manufacturing sites to mitigate duty exposure. These adjustments are not purely transactional; they affect strategic choices about where to locate final assembly, quality control laboratories, and inventory hubs to ensure timely delivery to clinical laboratories, veterinary hospitals, and field operations.

In tandem, tariff-driven cost dynamics have altered contracting conversations between suppliers and large institutional buyers. Procurement teams are more likely to demand contract clauses that account for duty changes or to favor suppliers capable of demonstrating consistent landed costs. As organizations adjust their supplier portfolios, smaller innovators with flexible production models may find opportunities to compete on responsiveness and niche performance advantages, while larger incumbents will need to leverage scale and supply chain control to preserve margin and maintain competitive pricing.

Furthermore, tariffs have amplified the importance of distribution channel strategy. Companies that successfully combine direct sales with regionally optimized distributor partnerships reduce the probability of duty-related delays and smooth revenue recognition across jurisdictions. In this context, strategic investments in customs expertise, local regulatory alignment, and supply chain transparency become essential components of commercial planning rather than back-office considerations.

Insights into how product formats animal categories analytical technologies clinical applications user types and distribution paths interact to shape development priorities and commercialization playbooks

Key segmentation insights reveal how differentiated needs across assay formats, animal populations, analytical technologies, clinical applications, end users, and distribution pathways drive product development and go-to-market decisions. Based on product type, diagnostics span Enzyme Linked Immunosorbent Assay and Lateral Flow Immunoassay formats, with ELISA further categorized into competitive, direct, indirect, and sandwich formats and lateral flow evolving to include competitive, multiplex, and sandwich designs that balance throughput, sensitivity, and simplicity. Based on animal type, solutions target companion animals and livestock populations where companion applications prioritize cats and dogs with a focus on outpatient clinical convenience, while livestock diagnostics address cattle, poultry, and swine where population-level screening, speed, and cost-efficiency dominate decision criteria.

Based on technology, the market encompasses colorimetric techniques, immunoassay platforms, and molecular diagnostics; immunoassay approaches further include chemiluminescence, ELISA, fluorescence, and lateral flow variants, whereas molecular diagnostics incorporate isothermal amplification and PCR modalities with isothermal methods subdividing into LAMP and RPA and PCR options spanning digital PCR and quantitative PCR. This technological stratification influences analytical sensitivity, user training needs, and instrumentation requirements. Based on application, diagnostic use cases include genetic tests, hormonal assays, infectious diseases, and parasitic infections, with genetic tests focusing on mutation detection and species identification, hormonal assays addressing reproductive and thyroid markers, infectious disease testing distinguishing bacterial, fungal, and viral etiologies, and parasitic diagnostics separating ectoparasite from endoparasite detection. Based on end user, the landscape engages clinical laboratories, pharmacies, research institutes, and veterinary hospitals, each with distinct procurement cycles, technical competencies, and data reporting expectations. Based on distribution channel, pathways span direct sales, eCommerce, and retail distributors, and the chosen channel influences customer engagement models, after-sales support, and inventory strategies.

Collectively, these segmentation layers inform product roadmaps and commercialization playbooks. For instance, multiplex lateral flow devices designed for poultry flock screening require different robustness and cost profiles than fluorescence-based immunoassays intended for specialty veterinary hospitals treating companion animals. Similarly, molecular diagnostics optimized for on-farm isothermal amplification balance ease of use with the need for minimal instrumentation, whereas qPCR and digital PCR solutions find traction in centralized laboratories that prioritize throughput and quantitation. Understanding these interdependencies helps companies prioritize investments, tailor regulatory submissions, and align distribution models with target end-user workflows.

Regional diagnostic ecosystems reveal distinct regulatory, infrastructure, and adoption patterns that drive differentiated strategies across Americas Europe Middle East Africa and Asia-Pacific

Geographic dynamics continue to define strategic priorities as regional regulatory frameworks, animal health infrastructures, and end-user behaviors diverge across major territories. In the Americas, diagnostic adoption is driven by integrated veterinary networks, sophisticated clinical laboratories, and a strong focus on companion animal wellness that supports demand for high-performance point-of-care solutions. The United States and parts of Latin America present contrasting procurement patterns, where centralized laboratory services remain important for large agricultural producers while independent clinics drive demand in urban companion animal markets.

In Europe, Middle East & Africa, fragmentation in regulatory regimes and varying levels of veterinary infrastructure create both complexity and opportunity. Western European markets emphasize compliance and clinical validation, reinforcing demand for assays that meet harmonized standards, while emerging markets across the region seek cost-effective, robust diagnostics that tolerate challenging logistics. The Middle East and select African markets often prioritize rapid deployment and simplicity to support outbreak response and routine herd-health management.

The Asia-Pacific region combines rapid adoption of advanced molecular diagnostics with large-scale livestock operations that demand scalable screening tools. Innovative distribution models and expanding eCommerce channels accelerate time-to-clinic for new products, and regional manufacturing capacity continues to rise, offering domestic suppliers competitive advantages in local markets. Across all regions, cross-border regulatory alignment efforts, investments in veterinary training, and digitization of diagnostic workflows are consistent themes that influence supplier strategy and product differentiation.

Company-level competitive advantages arise from technology integration regulatory rigor distribution scale and collaborative partnerships that accelerate adoption and sustain clinical trust

Competitive dynamics among companies operating in the veterinary rapid test landscape center on a few strategic dimensions: technological differentiation, regulatory and quality assurance capabilities, distribution reach, and the ability to deliver integrated solutions across hardware, reagents, and software. Market leaders typically pair validated assay chemistries with reliable point-of-care instruments and invest in post-market surveillance to sustain clinical confidence. Mid-sized innovators often focus on niche applications or animal segments where they can demonstrate clear performance advantages or cost efficiencies.

Partnerships and strategic alliances have become frequent mechanisms for accelerating market entry. Collaborations that combine diagnostic know-how with veterinary service providers, contract manufacturers, or digital health platforms can shorten time-to-adoption and broaden addressable markets. In addition, acquisitions that integrate complementary technologies, such as pairing molecular amplification expertise with rapid lateral flow reporting systems, enable firms to offer end-to-end diagnostic workflows.

Effective commercialization also depends on customer support and education. Companies that provide robust training materials, user-friendly digital guides, and responsive technical support secure higher levels of clinician trust and repeat procurement. Finally, firms that proactively engage with regulators and standards bodies to shape validation protocols and post-market surveillance practices reduce uncertainty and create barriers to entry for less-prepared competitors.

Practical strategic moves for diagnostic companies to accelerate adoption enhance resilience and create defensible commercial positions through design manufacturing distribution and partnerships

Industry leaders should pursue several actionable priorities to capture value while advancing animal health outcomes. First, accelerate user-centered product design that lowers training requirements and integrates with existing clinical workflows to maximize bedside utility. Second, invest in modular manufacturing and regional supply chains to mitigate tariff exposure and ensure continuity of supply under dynamic trade conditions. Third, prioritize strategic regulatory engagement and structured post-market evidence generation to demonstrate real-world performance and support broader clinical acceptance.

In addition, firms should expand distribution models by combining direct sales channels with eCommerce and selected retail distributor partnerships to meet diverse procurement preferences among clinical laboratories, veterinary hospitals, pharmacies, and research institutes. Vendors can also benefit from commercializing bundled offerings that pair diagnostics with data analytics and telemedicine services, thereby increasing the utility of test results and creating recurring revenue streams. Finally, pursue selective partnerships or technology licensing arrangements to accelerate access to complementary capabilities, while maintaining core competencies in assay development and quality management. Implementing these recommendations in an integrated manner will improve resilience and create a defensible competitive position across animal segments and geographies.

A transparent mixed-methods research approach combining stakeholder interviews regulatory literature and scenario-based analysis to derive actionable diagnostic insights

The research methodology underpinning this executive summary blends qualitative and quantitative approaches to build a robust evidence base while ensuring practical relevance to decision-makers. Primary research involved structured interviews and consultations with a cross-section of stakeholders, including veterinary clinicians, laboratory directors, procurement specialists, and diagnostics developers, to capture real-world needs, workflow constraints, and procurement behaviors. Secondary research synthesized peer-reviewed literature, regulatory guidance documents, and industry technical white papers to validate technological trends and standards of performance.

Analytical methods emphasized triangulation to reconcile disparate data points: technology performance attributes were cross-checked against clinical use cases and end-user expectations, while supply chain and tariff impacts were evaluated through scenario analysis to reveal strategic implications without relying on specific price forecasts. The methodology prioritized transparency in assumptions and documented limitations so that readers can interpret findings in the context of their own risk tolerance and operational constraints. Where appropriate, testing protocols and validation parameters were referenced to provide clarity on comparative performance claims across assay types.

A concise synthesis emphasizing the convergence of technological progress operational fit and strategic supply chain choices that determine diagnostic adoption outcomes

In conclusion, the veterinary rapid test ecosystem stands at the intersection of technical progress and practical imperatives. Advances in immunoassay and molecular technologies deliver improved analytical capabilities, while changes in care delivery models and procurement dynamics require diagnostics to be not only accurate but also accessible, affordable, and operationally fit for purpose. Trade policy fluctuations, including tariff shifts, further underscore the need for supply chain agility and regionally informed manufacturing strategies.

For industry stakeholders, the immediate priority is to align product development and commercialization plans with the nuanced needs of different animal types, end-users, and regional contexts. Companies that integrate user-centered product design, regulatory readiness, and distribution flexibility will be best positioned to capture adoption opportunities. Equally important is the cultivation of partnerships that extend technical capabilities and accelerate market access. By synthesizing these elements-technology, workflow integration, supply chain resilience, and strategic collaboration-organizations can convert diagnostic innovation into measurable improvements in animal health and operational outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of point-of-care rapid diagnostic tests in routine livestock health management to reduce disease outbreak risks
  • 5.2. Adoption of multiplex lateral flow assays for simultaneous detection of multiple animal pathogens in field settings
  • 5.3. Development of portable microfluidic devices enabling on-farm detection of zoonotic diseases in real time
  • 5.4. Increase in demand for smartphone-based rapid immunoassay platforms in small animal clinics and shelters
  • 5.5. Collaboration between biotech companies and veterinary associations to standardize rapid test validation protocols across regions
  • 5.6. Emergence of CRISPR-based diagnostic assays offering enhanced sensitivity for early detection of animal health threats in clinics
  • 5.7. Rising investment in veterinary diagnostic start-ups focusing on isothermal nucleic acid amplification for on-site testing of livestock diseases

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Rapid Test Market, by Product Type

  • 8.1. Enzyme Linked Immunosorbent Assay
    • 8.1.1. Competitive
    • 8.1.2. Direct
    • 8.1.3. Indirect
    • 8.1.4. Sandwich
  • 8.2. Lateral Flow Immunoassay
    • 8.2.1. Competitive
    • 8.2.2. Multiplex
    • 8.2.3. Sandwich

9. Veterinary Rapid Test Market, by Animal Type

  • 9.1. Companion Animals
    • 9.1.1. Cats
    • 9.1.2. Dogs
  • 9.2. Livestock
    • 9.2.1. Cattle
    • 9.2.2. Poultry
    • 9.2.3. Swine

10. Veterinary Rapid Test Market, by Technology

  • 10.1. Colorimetric Techniques
  • 10.2. Immunoassay
    • 10.2.1. Chemiluminescence
    • 10.2.2. ELISA
    • 10.2.3. Fluorescence
    • 10.2.4. Lateral Flow
  • 10.3. Molecular Diagnostics
    • 10.3.1. Isothermal Amplification
      • 10.3.1.1. LAMP
      • 10.3.1.2. RPA
    • 10.3.2. PCR
      • 10.3.2.1. Digital PCR
      • 10.3.2.2. qPCR

11. Veterinary Rapid Test Market, by Application

  • 11.1. Genetic Tests
    • 11.1.1. Mutation Detection
    • 11.1.2. Species Identification
  • 11.2. Hormonal Assays
    • 11.2.1. Reproductive
    • 11.2.2. Thyroid
  • 11.3. Infectious Diseases
    • 11.3.1. Bacterial
    • 11.3.2. Fungal
    • 11.3.3. Viral
  • 11.4. Parasitic Infections
    • 11.4.1. Ectoparasite
    • 11.4.2. Endoparasite

12. Veterinary Rapid Test Market, by End User

  • 12.1. Clinical Laboratories
  • 12.2. Pharmacies
  • 12.3. Research Institutes
  • 12.4. Veterinary Hospitals

13. Veterinary Rapid Test Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. eCommerce
  • 13.3. Retail Distributors

14. Veterinary Rapid Test Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Rapid Test Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Rapid Test Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. IDEXX Laboratories, Inc.
    • 17.3.2. Zoetis Inc.
    • 17.3.3. Abbott Laboratories
    • 17.3.4. Thermo Fisher Scientific Inc.
    • 17.3.5. Heska Corporation
    • 17.3.6. Merck & Co., Inc.
    • 17.3.7. Boehringer Ingelheim International GmbH
    • 17.3.8. Bimeda, Inc.
    • 17.3.9. ACON Laboratories, Inc.
    • 17.3.10. BioNote Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY RAPID TEST MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS VETERINARY RAPID TEST MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY RAPID TEST MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. VETERINARY RAPID TEST MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. VETERINARY RAPID TEST MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VETERINARY RAPID TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY RAPID TEST MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY RAPID TEST MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INDIRECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INDIRECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INDIRECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INDIRECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INDIRECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INDIRECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPETITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MULTIPLEX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MULTIPLEX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MULTIPLEX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MULTIPLEX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MULTIPLEX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MULTIPLEX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SANDWICH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COLORIMETRIC TECHNIQUES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COLORIMETRIC TECHNIQUES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COLORIMETRIC TECHNIQUES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COLORIMETRIC TECHNIQUES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COLORIMETRIC TECHNIQUES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY COLORIMETRIC TECHNIQUES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CHEMILUMINESCENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CHEMILUMINESCENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CHEMILUMINESCENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CHEMILUMINESCENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FLUORESCENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FLUORESCENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FLUORESCENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FLUORESCENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FLUORESCENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FLUORESCENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LAMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LAMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LAMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LAMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LAMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY LAMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RPA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RPA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RPA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RPA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RPA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RPA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY QPCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY QPCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY QPCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY QPCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY GENETIC TESTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MUTATION DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MUTATION DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MUTATION DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MUTATION DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MUTATION DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY MUTATION DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SPECIES IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SPECIES IDENTIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SPECIES IDENTIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SPECIES IDENTIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SPECIES IDENTIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY SPECIES IDENTIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY HORMONAL ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REPRODUCTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REPRODUCTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REPRODUCTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REPRODUCTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REPRODUCTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY REPRODUCTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY THYROID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY THYROID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY THYROID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY THYROID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY THYROID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY THYROID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY BACTERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FUNGAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FUNGAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FUNGAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FUNGAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FUNGAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY FUNGAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VIRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VIRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VIRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VIRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PARASITIC INFECTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ECTOPARASITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ECTOPARASITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ECTOPARASITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ECTOPARASITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ECTOPARASITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ECTOPARASITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENDOPARASITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENDOPARASITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENDOPARASITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENDOPARASITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENDOPARASITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY ENDOPARASITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL VETERINARY RAPID TEST MARKET SIZE, BY